During the past decade, Praxair Cancer Center at Danbury Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 9 clinical trials were completed, i.e. on average, 900% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Praxair Cancer Center at Danbury Hospital" #1 sponsor was "ECOG-ACRIN Cancer Research Group" with 4 trials, followed by "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "Acrotech Biopharma Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Praxair Cancer Center at Danbury Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Praxair Cancer Center at Danbury Hospital" are "Lung Cancer" (4 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Colorectal Cancer" (1 trials) and "Esophageal Cancer" (1 trials). Many other conditions were trialed in "Praxair Cancer Center at Danbury Hospital" in a lesser frequency.

Most popular intervention types in "Praxair Cancer Center at Danbury Hospital" are "Drug" (11 trials), "Other" (6 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (3 trials), "radiation therapy" (3 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Praxair Cancer Center at Danbury Hospital" are 12 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Praxair Cancer Center at Danbury Hospital". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Praxair Cancer Center at Danbury Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Praxair Cancer Center at Danbury Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".